Author:
Schrag Deborah,Chung Ki Young,Flombaum Carlos,Saltz Leonard
Publisher
Oxford University Press (OUP)
Reference13 articles.
1. Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer.
J Clin Oncol2003
;
21
:
2787
–99.
2. Mendelsohn J. Targeting the epidermal growth factor receptor for cancer therapy.
J Clin Oncol2002
;
20
(18 Suppl):
1S
–13S.
3. Prewett MC, Hooper AT, Bassi R, Ellis LM, Waksal HW, Hicklin DJ. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts.
Clin Cancer Res2002
;
8
:
994
–1003.
4. Saltz LB, Meropol NJ, Loehrer PJ Sr, Needle MN, Kopit J, Mayer RJ. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.
J Clin Oncol2004
;
22
:
1201
–8.
5. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
N Engl J Med2004
;
351
:
337
–45.
Cited by
212 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献